Jointown Pharmaceutical Group Company Limited’s Net Profit Dropped 24.2% in First Three Quarters of 2022

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 1.9 billion yuan in the first three quarters of 2022, down 24.2% year-on-year.

Meanwhile, the company posted 102.9 billion yuan in revenue, up 11.8% year-on-year.

At the end of the reporting period, it had 93 billion yuan in total assets and 64.8 billion yuan in total liabilities, with a liability-to-asset ratio of 69.7%.